Shionogi Pharma, Inc. - Strategic Analysis Review

GlobalData
August 31, 2010
21 Pages - SKU: GBDT2797023
Shionogi Pharma, Inc.(formerly Sciele Pharma, Inc.) is a subsidiary of Shionogi Inc.It is a pharmaceutical company engaged in the sales, marketing and distribution of branded prescription products of Shionogi Inc. like the cardiovascular, diabetes, pediatric and women's healthcare. The company markets and sells many products to primary care physicians, endocrinologists, cardiologists, obstetricians and gynecologists, and pediatricians.The company is mainly working from Atlanta, Georgia. The company is a US based group company of Shionogi & Co., Ltd.

Shionogi Pharma, Inc. Key Recent Developments

Apr 29, 2010: Impax Confirms Patent Challenge Relating To Fenoglide 40 And 120mg Tablets
Jan 07, 2010: Sciele Launches Adrenaclick Auto-Injector
Nov 19, 2009: Sciele Presents Data On Premature Ejaculation Drug
Oct 01, 2009: Sciele Pharma, Addrenex Submit sNDA To FDA For Clonicel
Oct 01, 2009: Addrenex Files sNDA Submission For Clonicel

GlobalData’s Shionogi Pharma, Inc. - Strategic Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
Note*: Some sections may be missing if data is unavailable for the company.

Reasons to buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.



More Pharmaceuticals Company reports by GlobalData

VistaGen Therapeutics , Inc. (VSTA) - Product Pipeline Analysis, 2014 Update by GlobalData
VistaGen Therapeutics , Inc. (VSTA) - Product Pipeline Analysis, 2014 UpdateSummaryVistaGen Therapeutics, Inc. (VistaGen) is a biopharmaceutical company. The company develops stem cell technology platform ...
Pierrel S.p.A. (PRL) - Financial and Strategic SWOT Analysis Review by GlobalData
Pierrel S.p.A. (PRL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile ...
Pharmstandard (PHST) - Financial and Strategic SWOT Analysis Review by GlobalData
Pharmstandard (PHST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has ...
NuCana BioMed Limited - Product Pipeline Analysis, 2014 Update by GlobalData
NuCana BioMed Limited - Product Pipeline Analysis, 2014 UpdateSummaryNuCana BioMed Limited (NuCana) is a biopharmaceutical company. The company discovers, develops and commercializes anti-cancer medicines. It ...
See all reports like this >>

 

SELECT A LICENSE

    Online Download  USD 125  
    Global Site License  USD 375  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!